| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/10/2006 | CA2518650A1 Clostridium botulinum toxin formulation and method for reducing weight |
| 03/09/2006 | WO2006025988A1 Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals |
| 03/09/2006 | WO2006025378A1 Remedy for hyperlipemia |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006025307A1 Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006025247A1 Mitochondria activators |
| 03/09/2006 | WO2006024628A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2005115358A3 Intranasal delivery of nucleic acid molecules |
| 03/09/2006 | US20060052458 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 03/09/2006 | US20060052456 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 03/09/2006 | US20060052451 Method |
| 03/09/2006 | US20060052449 4'-(2-phenoxy-ethylsulfanylmethyl)-biphenyl-3-carboxylic acid (3-dimethylamino-propyl)-amide oxalate; inhibiting release of the melanin concentrating hormone; treating Type II Diabetes, obesity |
| 03/09/2006 | US20060052447 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositios comprising them and processes for the preparation of them |
| 03/09/2006 | US20060052437 Combination of an hmg-coa reductase inhibitor and a nitrate ester |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051436 Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder |
| 03/09/2006 | US20060051425 Method of microencapsulation |
| 03/09/2006 | US20060051410 Pharmaceutical composition containing 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid |
| 03/09/2006 | US20060051399 Drugs/foods comprising peptides with high glutamine content produced from wheat gluten; hypercholesterolemia, hypertriglyceridemia, fatty liver, chronic hepatits C |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | DE102004040630A1 Kombinationstherapie mit Procain Combination therapy with procaine |
| 03/09/2006 | DE102004040006A1 Pharmazeutische Zusammensetzung, umfassend Galaktose, Selen, Vitamin E und/oder Phosphatidylcholin und pharmazeutische Verwendung von Galaktose A pharmaceutical composition comprising galactose, selenium, vitamin E and / or phosphatidylcholine and pharmaceutical use of galactose |
| 03/09/2006 | CA2578347A1 Mitochondria activators |
| 03/09/2006 | CA2576850A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632476A1 Acid addition salt of carbasugar amine derivative |
| 03/08/2006 | EP1632471A1 Racemic and optically pure metabolites of Sibutramine, their preparation, compositions comprising them and their use as Dopamine reuptake inhibitors |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632245A1 ICA512 couples insulin secretion and gene expression in Beta-cells |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632233A1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631558A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| 03/08/2006 | EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors |
| 03/08/2006 | EP1631291A2 Use of tyrosine kinase inhibitors to treat diabetes |
| 03/08/2006 | EP1631272A2 Methods of treating obesity and related disorders using tellurium and selenium compounds |
| 03/08/2006 | EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 03/08/2006 | EP1631269A2 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1465627B1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 03/08/2006 | EP1455602B1 Modified methionine rich food products and process for their manufacture |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1299090B1 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 03/08/2006 | EP1290013B1 Apo-ai/aii peptide derivatives |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1223913B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | EP0938476B1 Process for substituted pyridines |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1745063A Compound inhibiting dipeptidyl peptidase iv |
| 03/08/2006 | CN1744916A Preventive or remedy for diseases caused by hyperglycemia |
| 03/08/2006 | CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function |
| 03/08/2006 | CN1743321A Method for preparing thiazolidine acetate coprising phenyl propylidene |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1743002A Iron-supplementing preparation |
| 03/08/2006 | CN1742980A Chinese medicinal lotion for new-borne baby's removing jaundice |
| 03/08/2006 | CN1742963A Chinese medicine for treating diabets and nephritis |
| 03/08/2006 | CN1742962A Spirulina tablet and preparing method |
| 03/08/2006 | CN1742951A Health-care preparation for reducing blood-fat and raising human-body immunity |
| 03/08/2006 | CN1742950A Chinese medicine preparation made from corn stigma and preparing method |
| 03/08/2006 | CN1742949A Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use |
| 03/08/2006 | CN1742943A Instant preparation of sealwort and preparation process thereof |
| 03/08/2006 | CN1742936A Natural medicine preparation for treating diabets and preparing method |
| 03/08/2006 | CN1742933A Medicine for reducing blood sugar and its preparing method |
| 03/08/2006 | CN1742931A Instant preparation of radix polygonatic officinais and cassia tora and preparing process thereof |
| 03/08/2006 | CN1742880A Health product with fat-reducing and beauty function and puparation thereof |
| 03/08/2006 | CN1742879A Chinese medicine for reducing blood sugar and preparation thereof |
| 03/08/2006 | CN1742835A Xiaotongchui medicated liquor |
| 03/08/2006 | CN1742819A Medicine for preventing and treating diabets and kidney disease and preparing method |
| 03/08/2006 | CN1742808A Medicine composition with synergetic function |
| 03/08/2006 | CN1742803A Chinese medicine extract with function of reducing blood-sugar and preparing method |
| 03/08/2006 | CN1742781A Fat-reducing blood-fat-reducing Chinese medicine preparation |
| 03/08/2006 | CN1742763A Use of Wucenglong extract in preparing health-care product and medicines |
| 03/08/2006 | CN1742755A Red-yeast extract and preparation therefor |
| 03/08/2006 | CN1742754A Zhibituo dispersion tablet and preparing method |
| 03/08/2006 | CN1742753A Fat-reducing compound preparation |
| 03/08/2006 | CN1742748A Methy cobalamine dispersion tablet and preparing method |
| 03/08/2006 | CN1742736A Buckthorn extract, its preparing method and use in pharmaceutical process |
| 03/08/2006 | CN1742730A Method for preparing high stripping-degree hautriwaic glipizide capsule |
| 03/08/2006 | CN1742722A Method for resisting blood vessel generation |